It requires the integration of a molecular pathology driven approach throughout the therapeutic development cycle.
GPOL has three divisions to facilitate this important integration.
Purpose-built molecular profiling laboratory specialising in sequencing and custom assay design.
Assesses candidate novel therapeutic vulnerabilities to build a preclinical platform of evidence to support testing in the clinic.
Implementation of preclinical evidence into clinical trials.
